4.8 Article

Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy

Dan Wu et al.

Summary: Pyroptosis, a unique form of programmed cell death, has been closely associated with human diseases like inflammatory diseases and malignant tumors. Recent progress in cancer treatment based on nanoparticles-induced pyroptosis highlights design features and therapeutic advantages, while also proposing future directions in this emerging area.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Immunology

Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion

Nicole E. Scharping et al.

Summary: Continuous TCR signaling and hypoxia increase Blimp-1, suppressing mitochondrial reprogramming and generating reactive oxygen species, leading to T cell exhaustion. Mitigating T cell-intrinsic ROS and reducing tumor hypoxia can limit T cell exhaustion, synergizing with immunotherapy.

NATURE IMMUNOLOGY (2021)

Review Oncology

Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy

Sheera R. Rosenbaum et al.

Summary: Using immune checkpoint inhibitors (ICI) has significantly improved overall survival for certain cancer patients, but many tumors do not respond due to a lack of tumor-infiltrating lymphocytes (TIL). Converting immune cold tumors to hot tumors is a key obstacle in cancer treatment. Promoting tumor-localized necroptosis and pyroptosis may enhance responses to ICI.

CANCER DISCOVERY (2021)

Review Cell Biology

Future Directions in the Treatment of Osteosarcoma

Alannah Smrke et al.

Summary: Osteosarcoma, the most common primary bone sarcoma, is often diagnosed in the 2nd-3rd decades of life with outcomes not significantly changed for over thirty years. Response to neoadjuvant MAP chemotherapy is predictive of treatment outcome. Effective treatment with reduced toxicity is needed for high-risk patients, along with predictive biomarkers to guide therapy decisions.

CELLS (2021)

Article Engineering, Biomedical

Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity

Siqin Chen et al.

Summary: Conjugates of small-molecule anticancer drugs with a polyzwitterion that has negligible interaction with proteins and weak interaction with phospholipids can effectively eradicate large tumours and patient-derived tumour xenografts in mice by facilitating their transcytosis-mediated extravasation and infiltration into tumours, showcasing potential for translational anticancer nanomedicines.

NATURE BIOMEDICAL ENGINEERING (2021)

Review Oncology

Extracellular and nuclear PD-L1 in modulating cancer immunotherapy

Wenjun Xiong et al.

Summary: Understanding the regulatory mechanisms of the PD-1/PD-L1 axis is crucial for overcoming obstacles of PD-1/PD-L1 blockade. The roles of extracellular and nuclear PD-L1 play a critical role in regulating cancer immune evasion and immunotherapy.

TRENDS IN CANCER (2021)

Article Multidisciplinary Sciences

Gasdermin E suppresses tumour growth by activating anti-tumour immunity

Zhibin Zhang et al.

NATURE (2020)

Article Multidisciplinary Sciences

A bioorthogonal system reveals antitumour immune function of pyroptosis

Qinyang Wang et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity

Choong-Hwan Kwak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Indirect regulation of HMGB1 release by gasdermin D

Allen Volchuk et al.

NATURE COMMUNICATIONS (2020)

Review Cell Biology

Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies

Kaijian Zhou et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy

Samantha M. Morrissey et al.

TRENDS IN CANCER (2020)

Article Medicine, Research & Experimental

Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis

Zibo Li et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer

Dong Ha Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Review Immunology

Gasdermins and their role in immunity and inflammation

Pontus Orning et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia

F. Peng et al.

ONCOGENE (2018)

Article Oncology

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Marie-Nicole Theodoraki et al.

CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

Yupeng Wang et al.

NATURE (2017)

Review Oncology

Mitochondria, Bioenergetics and Apoptosis in Cancer

Peter J. Burke

TRENDS IN CANCER (2017)

Article Oncology

Dual-targeting of aberrant glucose metabolism in glioblastoma

Han Shen et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

Article Multidisciplinary Sciences

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Jianjin Shi et al.

NATURE (2015)

Article Pharmacology & Pharmacy

Nitric oxide induces apoptosis in GM-CSF-treated eosinophils via caspase-6-dependent lamin and DNA fragmentation

Pinja Ilmarinen-Salo et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)

Article Biochemistry & Molecular Biology

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

Francois Ghiringhelli et al.

NATURE MEDICINE (2009)

Review Oncology

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

E. D. Michelakis et al.

BRITISH JOURNAL OF CANCER (2008)